Lotus is now a fast growing specialty generic company in Asia. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. The company boasts a best in class R&D and manufacturing platform across Taiwan and Korea. Further, Lotus can reach nearly every global market with its high value pipeline through the companys direct markets, relationship with Alvogens commercial units spanning over 30 countries, and through alliances with top-tier pharma companies.